These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 17270161)
1. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Shiroshita-Takeshita A; Brundel BJ; Burstein B; Leung TK; Mitamura H; Ogawa S; Nattel S Cardiovasc Res; 2007 Apr; 74(1):75-84. PubMed ID: 17270161 [TBL] [Abstract][Full Text] [Related]
2. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling. Sakabe M; Shiroshita-Takeshita A; Maguy A; Dumesnil C; Nigam A; Leung TK; Nattel S Circulation; 2007 Nov; 116(19):2101-9. PubMed ID: 17967774 [TBL] [Abstract][Full Text] [Related]
3. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Shiroshita-Takeshita A; Schram G; Lavoie J; Nattel S Circulation; 2004 Oct; 110(16):2313-9. PubMed ID: 15477401 [TBL] [Abstract][Full Text] [Related]
4. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure. Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729 [TBL] [Abstract][Full Text] [Related]
6. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Cha TJ; Ehrlich JR; Zhang L; Shi YF; Tardif JC; Leung TK; Nattel S Circulation; 2004 Jan; 109(3):412-8. PubMed ID: 14718405 [TBL] [Abstract][Full Text] [Related]
7. Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure. Cha TJ; Ehrlich JR; Zhang L; Nattel S Circulation; 2004 Sep; 110(12):1520-6. PubMed ID: 15381657 [TBL] [Abstract][Full Text] [Related]
8. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure. Hanna N; Cardin S; Leung TK; Nattel S Cardiovasc Res; 2004 Aug; 63(2):236-44. PubMed ID: 15249181 [TBL] [Abstract][Full Text] [Related]
9. Xanthine oxidase inhibition prevents atrial fibrillation in a canine model of atrial pacing-induced left ventricular dysfunction. Sakabe M; Fujiki A; Sakamoto T; Nakatani Y; Mizumaki K; Inoue H J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1130-5. PubMed ID: 22587612 [TBL] [Abstract][Full Text] [Related]
10. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs. Yang SS; Han W; Zhou HY; Dong G; Wang BC; Huo H; Wei N; Cao Y; Zhou G; Xiu CH; Li WM Chin Med J (Engl); 2008 Jan; 121(1):38-42. PubMed ID: 18208664 [TBL] [Abstract][Full Text] [Related]
11. Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Burstein B; Libby E; Calderone A; Nattel S Circulation; 2008 Apr; 117(13):1630-41. PubMed ID: 18347210 [TBL] [Abstract][Full Text] [Related]
12. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477 [TBL] [Abstract][Full Text] [Related]
13. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy. Brigadeau F; Gelé P; Wibaux M; Marquié C; Martin-Nizard F; Torpier G; Fruchart JC; Staels B; Duriez P; Lacroix D J Cardiovasc Pharmacol; 2007 Jun; 49(6):408-15. PubMed ID: 17577106 [TBL] [Abstract][Full Text] [Related]
14. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442 [TBL] [Abstract][Full Text] [Related]
15. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure. Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446 [TBL] [Abstract][Full Text] [Related]
16. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway. Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887 [TBL] [Abstract][Full Text] [Related]